Verrica Pharmaceuticals Inc.
VRCA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001660334
In the last 90 days, Verrica Pharmaceuticals Inc. insiders filed 4 open-market purchases and 0 sales; 43 institutions reported holding it in 13F filings for Q2 2026, worth $28.5M in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Verrica Pharmaceuticals Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Of which not filed for Q4 2024 | Q4 2024 | Change |
|---|---|---|---|---|
| Holders | 79 | 2 | 81 | +4 |
| Shares | 14.9M | 10.0K | 30.0M | +15.1M (+101.8%) |
| Value | $21.6M | $14.5K | $21.0M | −$553.2K (−2.6%) |
2 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (20)
Institutions that held Verrica Pharmaceuticals Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Armistice Capital, LLC | 8,921,000 | $6.24M | 0.15% |
| Caligan Partners LP | 7,429,687 | $5.20M | 1.32% |
| Boothbay Fund Management, LLC | 2,587,046 | $1.81M | 0.06% |
| Sovran Advisors, LLC | 407,050 | $266.6K | 0.04% |
| Heights Capital Management, Inc | 351,142 | $245.8K | 0.12% |
| Invesco Ltd. | 45,132 | $31.6K | 0.00% |
| PFG Investments, LLC | 27,843 | $19.5K | 0.00% |
| Citadel Advisors LLC | 20,286 | $14.2K | 0.00% |
| JustInvest LLC | 18,069 | $12.6K | 0.00% |
| AQR Capital Management LLC | 14,436 | $10.1K | 0.00% |
| Virtu Financial LLC | 13,047 | $9.00K | 0.00% |
| M&T Bank Corp | 10,833 | $7.58K | 0.00% |
| Ground Swell Capital, LLC | 10,525 | $7.37K | 0.02% |
| Wealth Enhancement Advisory Services, LLC | 10,133 | $7.09K | 0.00% |
| Legacy Trust | 6,500 | $4.55K | 0.00% |
| Police & Firemen's Retirement System of New Jersey | 3,807 | $2.67K | 0.00% |
| New England Capital Financial Advisors LLC | 2,000 | $1.40K | 0.00% |
| Group One Trading, L.P. | 31 | $22 | 0.00% |
| MAI Capital Management | 21 | $15 | 0.00% |
| SBI Securities Co., Ltd. | 8 | $6 | 0.00% |
Sold out (16)
Institutions that held Verrica Pharmaceuticals Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Propel Bio Management, LLC | 344,937 | $500.2K |
| Simplify Asset Management Inc. | 200,000 | $290.0K |
| ExodusPoint Capital Management, LP | 186,132 | $270.0K |
| Wellington Management Group LLP | 114,363 | $165.8K |
| Nuveen Asset Management, LLC | 95,032 | $137.8K |
| Squarepoint Ops LLC | 86,039 | $124.8K |
| Verition Fund Management LLC | 61,640 | $89.4K |
| Sanctuary Advisors, LLC | 60,000 | $59.7K |
| Two Sigma Securities, LLC | 35,980 | $52.2K |
| Susquehanna International Group, LLP | 28,162 | $40.8K |
| Sherbrooke Park Advisers LLC | 24,865 | $36.1K |
| Millennium Management LLC | 20,030 | $29.0K |
| Stifel Financial Corp | 13,914 | $20.2K |
| Truist Financial Corp | 10,545 | $15.3K |
| Russell Investments Group, Ltd. | 1,931 | $2.80K |
| SRS Capital Advisors, Inc. | 241 | $350 |
Not filed for Q4 2024 yet (2)
Institutions that held Verrica Pharmaceuticals Inc. at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| FinTrust Capital Advisors, LLC | 10,000 | $14.5K |
| Carmichael Hill & Associates, Inc. | 21 | $31 |